Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 470

1.

Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.

Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, Green C, Kritchevsky SB, Chertow GM, Cummings SR, Shlipak MG; Health ABC study.

Am Heart J. 2008 Jan;155(1):62-8. Epub 2007 Oct 24.

PMID:
18082491
2.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
3.

Cystatin C and the risk of death and cardiovascular events among elderly persons.

Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C.

N Engl J Med. 2005 May 19;352(20):2049-60.

4.

Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study.

Bibbins-Domingo K, Chertow GM, Fried LF, Odden MC, Newman AB, Kritchevsky SB, Harris TB, Satterfield S, Cummings SR, Shlipak MG.

Arch Intern Med. 2006 Jul 10;166(13):1396-402.

PMID:
16832005
5.

Cystatin C concentration as a risk factor for heart failure in older adults.

Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG; Cardiovascular Health Study.

Ann Intern Med. 2005 Apr 5;142(7):497-505.

PMID:
15809461
6.

Kidney function as a predictor of noncardiovascular mortality.

Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB.

J Am Soc Nephrol. 2005 Dec;16(12):3728-35. Epub 2005 Oct 26.

7.
8.

Chronic kidney disease and functional limitation in older people: health, aging and body composition study.

Fried LF, Lee JS, Shlipak M, Chertow GM, Green C, Ding J, Harris T, Newman AB.

J Am Geriatr Soc. 2006 May;54(5):750-6.

PMID:
16696739
9.

Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.

Peralta CA, Lee A, Odden MC, Lopez L, Zeki Al Hazzouri A, Neuhaus J, Haan MN.

J Am Geriatr Soc. 2013 Jan;61(1):90-5. doi: 10.1111/jgs.12040. Epub 2012 Dec 18.

10.

Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study.

Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG.

Kidney Int. 2007 Feb;71(3):239-44. Epub 2006 Dec 20.

11.

Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment.

Lind M, Jansson JH, Nilsson TK, Järvholm LS, Johansson L.

Thromb Res. 2013 Aug;132(2):e77-82. doi: 10.1016/j.thromres.2013.06.011. Epub 2013 Jul 5.

PMID:
23834818
12.

Cystatin C as a risk factor for outcomes in chronic kidney disease.

Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, Sarnak MJ.

Ann Intern Med. 2007 Jul 3;147(1):19-27.

PMID:
17606957
13.

Association of cystatin C and depression in healthy elders: the health, aging and body composition study.

Minev E, Unruh M, Shlipak MG, Simsonick E, Yaffe K, Leak TS, Newman AB, Fried LF; Health ABC Study.

Nephron Clin Pract. 2010;116(3):c241-6. doi: 10.1159/000317205. Epub 2010 Jul 2.

14.

Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.

Rebholz CM, Grams ME, Matsushita K, Inker LA, Foster MC, Levey AS, Selvin E, Coresh J.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):941-8. doi: 10.2215/CJN.10101014. Epub 2015 Mar 30.

15.
16.

Cystatin C and sudden cardiac death risk in the elderly.

Deo R, Sotoodehnia N, Katz R, Sarnak MJ, Fried LF, Chonchol M, Kestenbaum B, Psaty BM, Siscovick DS, Shlipak MG.

Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):159-64. doi: 10.1161/CIRCOUTCOMES.109.875369. Epub 2010 Jan 19.

17.
18.

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.

Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF.

J Am Soc Nephrol. 2006 Jan;17(1):254-61. Epub 2005 Nov 2.

19.

Homoarginine, kidney function and cardiovascular mortality risk.

Tomaschitz A, Meinitzer A, Pilz S, Rus-Machan J, Genser B, Drechsler C, Grammer T, Krane V, Ritz E, Kleber ME, Pieske B, Kraigher-Krainer E, Fahrleitner-Pammer A, Wanner C, Boehm BO, März W.

Nephrol Dial Transplant. 2014 Mar;29(3):663-71. doi: 10.1093/ndt/gft512. Epub 2014 Jan 6.

PMID:
24398889
20.

African ancestry, socioeconomic status, and kidney function in elderly African Americans: a genetic admixture analysis.

Peralta CA, Ziv E, Katz R, Reiner A, Burchard EG, Fried L, Kwok PY, Psaty B, Shlipak M.

J Am Soc Nephrol. 2006 Dec;17(12):3491-6. Epub 2006 Nov 2.

Supplemental Content

Support Center